News & Press Releases
Press Releases
In the News
- 2010-02-05
- Bloomberg/BusinessWeek: Fate Therapeutics, MIT Scientist Get Stem Cell Patent
- 2010-02-05
- San Diego Daily Transcript: Fate Therapeutics Receives Patent Allowance
- 2009-01-06
- La Jolla Light: Science to Watch
- 2009-12-18
- The Scientist: The top 5 people of 2009
- 2009-12-15
- Forbes: Sneak Peek 2010
- 2009-12-10
- BioBusiness.TV: Fate Therapeutics Modulates Cell Fate (video)
- 2009-12-00
- Drug Discovery News: Tempting Fate
- 2009-12-00
- The Scientist: Top 10 Innovations
- 2009-11-16
- Wall Street Journal Blog: In The Money
- 2009-11-16
- VentureWire: OVP Venture Steps Up To Lead $30M Series B For Fate Therapeutics (complimentary access)
- 2009-11-16
- GEN: Fate Therapeutics Scores $30M to Advance Its Adult Stem Cell Technology
- 2009-11-16
- Fierce Biotech: Fate ready to expand with $30M Series B
- 2009-11-16
- In Vivo Blog: Fate Seals $30 M Series B, Gets Corporate Venture On Board
- 2009-11-16
- San Diego Business Journal: Fate Meets its Series B Funding of $30M
- 2009-11-16
- Xconomy: Fate Therapeutics Bags $30M Venture Deal, Led by OVP, to Develop “Industrialized” Stem Cells
- 2009-11-00
- The Scientist: Scientist to Watch: Sheng Ding
- 2009-10-29
- SciBX: More iPS cells in less time (subscription required)
- 2009-10-19
- FierceBiotech: Fate Therapeutics wins key to iPS breakthrough
- 2009-10-19
- GenomeWeb: Scripps Method May Enable Commercial-Scale Manufacture of iPSCs (registration required)
- 2009-10-19
- San Diego Business Journal: Partners Speed Process of Reprogramming Stem Cells
- 2009-10-18
- Xconomy: Faster, Cheaper Stem Cells: Fate Therapeutics Co-Founder, With Scripps Team, Finds Key
- 2009-09-30
- Xconomy: Fate Therapeutics Growing Fast on “Industrialized” Stem Cell Technology
- 2009-09-21
- FierceBiotech: Emerging Drug Developer: Fate Therapeutics
- 2009-08-01
- Pharmaceutical Executive: Betting the Pharma - Hot Biotech - Top 10 Companies with Bright Prospects
- 2009-07-17
- Technology Review: Provoking Our Inner Stem Cells
- 2009-07-09
- Bloomberg: Novartis, Fate Therapeutics Race for Stem-Cell Drug
- 2009-07-01
- Biotech Transfer Week: Fate Therapeutics Licenses Stem-Cell Modulators for Bone Regeneration from UCLA
- 2009-07-00
- The Scientist: Success with iPSCs
- 2009-06-29
- San Diego Business Journal: Forum Exchanges Ideas Impacting Drug Approvals
- 2009-06-09
- WIRED Science: Forgotten Drug Helps Stem Cells Repair Bone Marrow
- 2009-06-00
- Drug Discovery News: Catalyst to ‘Industrialize’ Stem Cell Tech
- 2009-06-01
- San Diego Business Journal: Fate Tests Experimental Drug: Treatment Would Help Replenish Blood Systems
- 2009-05-27
- Xconomy: Fate Therapeutics Starts First Clinical Trial of Drug to Boost Stem Cell Transplants
- 2009-05-26
- Outsourcing Pharma.com: Fate seeks partners to be iPS Catalyst
- 2009-05-20
- Biotech Transfer Week: Fate Therapeutics Amasses More Academic Stem Cell IP with Children's Hospital Boston Deal (registration required)
- 2009-05-19
- SDBN Blog: BIO 2009: Stem Cell Companies’ ‘Fate’ Relies on Interdisciplinary Business Models
- 2009-05-18
- Mass High Tech: Stem cell startup claims IP from local hospitals
- 2009-05-15
- Xconomy: Stem Cell Tech in Fate's Hands
- 2009-05-15
- San Diego Business Journal: Fate Therapeutics Gains Rights to Stem Cell Technology
- 2009-05-01
- Pharma Magazine (Editorial): Restoring the Commitment to Science
- 2009-05-00
- Associated Content: Researchers Succeed in Creating Stable Stem Cells from Adult Cells
- 2009-04-24
- San Diego Union-Tribune: Consortium targets next-level stem research
- 2009-04-23
- Reuters: New stem cell method requires a little soak
- 2009-04-23
- The Scientist: Purely protein pluripotency
- 2009-04-23
- Xconomy: Fate Therapeutics and Stemgent Team Up to Offer Stem Cell Advances to the Research Market
- 2009-04-23
- San Diego Union-Tribune: Discovery could lead to new method for creating stem cells
- 2009-04-23
- San Diego Business Journal: Stem Cell Breakthrough Reported
- 2009-04-23
- Wall Street Journal: Chemist Cites Advance in Stem-Cell Field
- 2009-04-23
- Forbes/Healthday: Scientists Find New Way to Create Stem Cells
- 2009-04-23
- MSN Health: Scientists Find New Way to Create Stem Cells
- 2009-04-23
- Mass High Tech: Stemgent, Fate Therapeutics launch stem cell platform
- 2009-04-07
- Journal of the National Cancer Institute: Drugging the Wnt Pathway: Problems and Progress (subscription required)
- 2009-04-00
- Start-Up: Fate Therapeutics Inc. (subscription required)
- 2009-04-00
- The Scientist: Stem Cell Rat Race (registration required)
- 2009-03-13
- Xconomy: Fate Therapeutics Adds Scientific Muscle, Advancing Stem Cell Technology into First Clinical Trial
- 2009-03-04
- Biotech Transfer Week: Fate Therapeutics Bolsters Academic Stem-Cell IP Portfolio with Whitehead Institute License (registration required)
- 2009-02-23
- San Diego Business Journal: In Fate’s Hands
- 2009-02-12
- SciBx: Grasping the Hedgehog (subscription required)
- 2009-01-22
- SciBx: A niche play for stem cells (subscription required)
- 2009-01-06
- BioWorld Today: Rats!
- 2008-12-30
- Nature Reports Stem Cells: Stem cell therapies the old-fashioned way
- 2008-10-09
- Cell Stem Cell: Starting Up with Stem Cells
- 2008-01-04
- BioCentury: Fate: Potentiating stem cells
- 2007-12-03
- BioWorld Today: A Different Approach To Stem Cell Therapy:Fate Tempts VCs With Viable Stem Cell Business Model
- 2007-12-03
- Mass High Tech: Hub biotech biggies launch new stem cell startup
- 2007-11-29
- Forbes: Regenerators
- 2007-11-29
- Seattle Post-Intelligencer: Adult stem cell startup Fate Therapeutics scores $12 million
- 2007-11-29
- Puget Sound Business Journal: Scientists form new Seattle biotech, backed by $12M
Please see disclaimer on third party links.
